Atlas Trials

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors

Clinical trial NCT02038218 · COMPLETED

Trial details

NCT number
NCT02038218
Sponsor
DEKK-TEC, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Brain TumorsMetastatic Malignant Neoplasm to Brain
Start date
2013-09-01
Primary completion
2016-05-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.